AAAAAA

   
Results: 1-12 |
Results: 12
Comparison of lymphoid neoplasm classification - A blinded study between acommunity and an academic setting
Authors: Siebert, JD Harvey, LAC Fishkin, PAS Knost, JA Ehsan, A Smir, BN Craig, FE
Citation: Jd. Siebert et al., Comparison of lymphoid neoplasm classification - A blinded study between acommunity and an academic setting, AM J CLIN P, 115(5), 2001, pp. 650-655
Comparison of individual urologists' performance
Authors: Sommer, F Ehsan, A Klotz, T Haupt, G Caspers, HP Engelmann, U
Citation: F. Sommer et al., Comparison of individual urologists' performance, EUR UROL, 39(4), 2001, pp. 369-374
Risk adjustment for evaluating the outcome of urological operative procedures
Authors: Sommer, F Ehsan, A Caspers, HP Klotz, T Engelmann, U
Citation: F. Sommer et al., Risk adjustment for evaluating the outcome of urological operative procedures, J UROL, 166(3), 2001, pp. 968-972
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide genetherapy
Authors: Ehsan, A Mann, MJ Dell'Acqua, G Dzau, VJ
Citation: A. Ehsan et al., Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide genetherapy, J THOR SURG, 121(4), 2001, pp. 714-722
Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics
Authors: Dzau, VJ Mann, MJ Ehsan, A Griese, DP
Citation: Vj. Dzau et al., Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics, J THOR SURG, 121(2), 2001, pp. 206-216
Experimental models of arteriovenous grafting
Authors: Ehsan, A Mann, MJ Dzau, VJ
Citation: A. Ehsan et al., Experimental models of arteriovenous grafting, CONTEMP CAR, 2001, pp. 61-78
Antisense and gene therapy to prevent restenosis
Authors: Ehsan, A Mann, MJ
Citation: A. Ehsan et Mj. Mann, Antisense and gene therapy to prevent restenosis, VASC MED, 5(2), 2000, pp. 103-114
Accumulation of p53 in infectious mononucleosis tissues
Authors: Ehsan, A Fan, HX Eagan, PA Siddiqui, HA Gulley, ML
Citation: A. Ehsan et al., Accumulation of p53 in infectious mononucleosis tissues, HUMAN PATH, 31(11), 2000, pp. 1397-1403
Studies on a polyoxypropylene glycol-based antifoaming agent in MSF plants
Authors: Imam, M Al-Rasheed, R Al-Tisan, I Abdulgader, AY Mustafa, GM Al-Mobayed, AS Ehsan, A Brose, D
Citation: M. Imam et al., Studies on a polyoxypropylene glycol-based antifoaming agent in MSF plants, DESALINATN, 129(2), 2000, pp. 187-196
Evaluation of polyphosphonate antiscalant at a low dose rate in the Al-Jubail Phase II MSF plant, Saudi Arabia
Authors: Hamed, OA Al-Sofi, MAK Imam, M Mardouf, KB Al-Mobayed, AS Ehsan, A
Citation: Oa. Hamed et al., Evaluation of polyphosphonate antiscalant at a low dose rate in the Al-Jubail Phase II MSF plant, Saudi Arabia, DESALINATN, 128(3), 2000, pp. 275-280
Gene therapy for cardiovascular disease and vascular grafts
Authors: Ehsan, A Mann, MJ Dzau, VJ
Citation: A. Ehsan et al., Gene therapy for cardiovascular disease and vascular grafts, GENE THERAPY, 2000, pp. 421-438
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial
Authors: Mann, MJ Whittemore, AD Donaldson, MC Belkin, M Conte, MS Polak, JF Orav, EJ Ehsan, A Dell'Acqua, G Dzau, VJ
Citation: Mj. Mann et al., Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial, LANCET, 354(9189), 1999, pp. 1493-1498
Risultati: 1-12 |